Barely Significant
← all excerpts

Morpho-Molecular Assessment Indicates New Prognostic Aspects and Personalized Therapeutic Options in Sinonasal Melanoma.

Cancers (Basel) · 2019 · PMC6770844 · PMID 31500314

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)
However, patients with NRAS mutations showed a trend towards prolonged distant metastasis-free survival ( Figure 1 d) (Log-rank test, p = 0.06), but no difference in disease specific survival ( Figure 1 e, p = 0.9), while the two groups ( NRAS mutant vs.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.